Dr. Lungu has over 30 years’ experience in drug development, clinical research, Pharmacovigilance and quality assurance. He conducted more than 160 Pharmacovigilance quality system audits in more than 40 countries around the globe. Apart of audits, he is a dedicated trainer of the official EMA EudraVigilance and XEVMPD training programmes and led over 300 offerings since 2004.

PV professional with immense experience with critical PV processes gained through execution as well as its successful leadership and management. The key areas of Jan’s expertise are strategic consulting on full PV outsourcing including expert advice and guidance on the implementation of AI-powered safety systems, Safety data mining in global databases, ICSR Management, EV and XEVMPD maintenance, EU QPPV activities, signal management, PSMF development/maintenance, medical writing, and audits/inspections.

Monika Gappa is a Pharmacovigilance professional with a degree in Pharmacy from Medical University in Gdansk, Poland. She has 4 years of expertise in PV with a wide background in the fields of XEVMPD and EudraVigilance set-up and maintenance. Additionally, she has managed local, global and regulatory intelligence projects as well as supported Health Authority inspections and client audits. Since 2020, she is the PV Network Coordinator of Local Contact Persons for Pharmacovigilance for more than 25 countries. It is the broad range of experiences that gives Monika a different perspective on the industry she works in.